Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 617

1.

Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype.

Terao C, Brynedal B, Chen Z, Jiang X, Westerlind H, Hansson M, Jakobsson PJ, Lundberg K, Skriner K, Serre G, Rönnelid J, Mathsson-Alm L, Brink M, Dahlqvist SR, Padyukov L, Gregersen PK, Barton A, Alfredsson L, Klareskog L, Raychaudhuri S.

Am J Hum Genet. 2019 Oct 3;105(4):880. doi: 10.1016/j.ajhg.2019.09.018. No abstract available.

2.

Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study.

Boman A, Brink M, Lundquist A, Hansson M, Mathsson-Alm L, Rönnelid J, Berglin E, Holmdahl R, Skriner K, Serre G, Klareskog L, Rantapää-Dahlqvist S.

RMD Open. 2019 Sep 3;5(2):e000946. doi: 10.1136/rmdopen-2019-000946. eCollection 2019.

3.

Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts.

Sun M, Rethi B, Krishnamurthy A, Joshua V, Circiumaru A, Hensvold AH, Ossipova E, Grönwall C, Liu Y, Engstrom M, Catrina SB, Steen J, Malmstrom V, Klareskog L, Svensson C, Ospelt C, Wähämaa H, Catrina AI.

Ann Rheum Dis. 2019 Dec;78(12):1621-1631. doi: 10.1136/annrheumdis-2018-214967. Epub 2019 Sep 3.

4.

Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype.

Terao C, Brynedal B, Chen Z, Jiang X, Westerlind H, Hansson M, Jakobsson PJ, Lundberg K, Skriner K, Serre G, Rönnelid J, Mathsson-Alm L, Brink M, Dahlqvist SR, Padyukov L, Gregersen PK, Barton A, Alfredsson L, Klareskog L, Raychaudhuri S.

Am J Hum Genet. 2019 Sep 5;105(3):616-624. doi: 10.1016/j.ajhg.2019.08.002. Epub 2019 Aug 29. Erratum in: Am J Hum Genet. 2019 Oct 3;105(4):880.

5.

Occupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control study.

Ilar A, Klareskog L, Saevarsdottir S, Wiebert P, Askling J, Gustavsson P, Alfredsson L.

RMD Open. 2019 Jul 11;5(2):e000978. doi: 10.1136/rmdopen-2019-000978. eCollection 2019.

6.

How to communicate in science.

Klareskog L, Catrina AI, Svensson C, Malmstrom V.

Ann Rheum Dis. 2019 Aug 13. pii: annrheumdis-2019-216016. doi: 10.1136/annrheumdis-2019-216016. [Epub ahead of print] No abstract available.

PMID:
31409591
7.

Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa.

Watson HJ, Yilmaz Z, Thornton LM, Hübel C, Coleman JRI, Gaspar HA, Bryois J, Hinney A, Leppä VM, Mattheisen M, Medland SE, Ripke S, Yao S, Giusti-Rodríguez P; Anorexia Nervosa Genetics Initiative, Hanscombe KB, Purves KL; Eating Disorders Working Group of the Psychiatric Genomics Consortium, Adan RAH, Alfredsson L, Ando T, Andreassen OA, Baker JH, Berrettini WH, Boehm I, Boni C, Perica VB, Buehren K, Burghardt R, Cassina M, Cichon S, Clementi M, Cone RD, Courtet P, Crow S, Crowley JJ, Danner UN, Davis OSP, de Zwaan M, Dedoussis G, Degortes D, DeSocio JE, Dick DM, Dikeos D, Dina C, Dmitrzak-Weglarz M, Docampo E, Duncan LE, Egberts K, Ehrlich S, Escaramís G, Esko T, Estivill X, Farmer A, Favaro A, Fernández-Aranda F, Fichter MM, Fischer K, Föcker M, Foretova L, Forstner AJ, Forzan M, Franklin CS, Gallinger S, Giegling I, Giuranna J, Gonidakis F, Gorwood P, Mayora MG, Guillaume S, Guo Y, Hakonarson H, Hatzikotoulas K, Hauser J, Hebebrand J, Helder SG, Herms S, Herpertz-Dahlmann B, Herzog W, Huckins LM, Hudson JI, Imgart H, Inoko H, Janout V, Jiménez-Murcia S, Julià A, Kalsi G, Kaminská D, Kaprio J, Karhunen L, Karwautz A, Kas MJH, Kennedy JL, Keski-Rahkonen A, Kiezebrink K, Kim YR, Klareskog L, Klump KL, Knudsen GPS, La Via MC, Le Hellard S, Levitan RD, Li D, Lilenfeld L, Lin BD, Lissowska J, Luykx J, Magistretti PJ, Maj M, Mannik K, Marsal S, Marshall CR, Mattingsdal M, McDevitt S, McGuffin P, Metspalu A, Meulenbelt I, Micali N, Mitchell K, Monteleone AM, Monteleone P, Munn-Chernoff MA, Nacmias B, Navratilova M, Ntalla I, O'Toole JK, Ophoff RA, Padyukov L, Palotie A, Pantel J, Papezova H, Pinto D, Rabionet R, Raevuori A, Ramoz N, Reichborn-Kjennerud T, Ricca V, Ripatti S, Ritschel F, Roberts M, Rotondo A, Rujescu D, Rybakowski F, Santonastaso P, Scherag A, Scherer SW, Schmidt U, Schork NJ, Schosser A, Seitz J, Slachtova L, Slagboom PE, Slof-Op 't Landt MCT, Slopien A, Sorbi S, Świątkowska B, Szatkiewicz JP, Tachmazidou I, Tenconi E, Tortorella A, Tozzi F, Treasure J, Tsitsika A, Tyszkiewicz-Nwafor M, Tziouvas K, van Elburg AA, van Furth EF, Wagner G, Walton E, Widen E, Zeggini E, Zerwas S, Zipfel S, Bergen AW, Boden JM, Brandt H, Crawford S, Halmi KA, Horwood LJ, Johnson C, Kaplan AS, Kaye WH, Mitchell JE, Olsen CM, Pearson JF, Pedersen NL, Strober M, Werge T, Whiteman DC, Woodside DB, Stuber GD, Gordon S, Grove J, Henders AK, Juréus A, Kirk KM, Larsen JT, Parker R, Petersen L, Jordan J, Kennedy M, Montgomery GW, Wade TD, Birgegård A, Lichtenstein P, Norring C, Landén M, Martin NG, Mortensen PB, Sullivan PF, Breen G, Bulik CM.

Nat Genet. 2019 Aug;51(8):1207-1214. doi: 10.1038/s41588-019-0439-2. Epub 2019 Jul 15.

PMID:
31308545
8.

Understanding and Prevention of the Evolution Toward Autoimmune Rheumatoid Arthritis: The New Challenge.

Klareskog L.

Clin Ther. 2019 Jul;41(7):1232-1234. doi: 10.1016/j.clinthera.2019.04.034. Epub 2019 Jun 10. No abstract available.

PMID:
31196654
9.

Interplay between alcohol, smoking and HLA genes in RA aetiology.

Hedström AK, Hössjer O, Klareskog L, Alfredsson L.

RMD Open. 2019 May 9;5(1):e000893. doi: 10.1136/rmdopen-2019-000893. eCollection 2019.

10.

Interplay between obesity and smoking with regard to RA risk.

Hedström AK, Klareskog L, Alfredsson L.

RMD Open. 2019 Apr 16;5(1):e000856. doi: 10.1136/rmdopen-2018-000856. eCollection 2019.

11.

Periodontal Health and Oral Microbiota in Patients with Rheumatoid Arthritis.

Eriksson K, Fei G, Lundmark A, Benchimol D, Lee L, Hu YOO, Kats A, Saevarsdottir S, Catrina AI, Klinge B, Andersson AF, Klareskog L, Lundberg K, Jansson L, Yucel-Lindberg T.

J Clin Med. 2019 May 8;8(5). pii: E630. doi: 10.3390/jcm8050630.

12.

Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population.

Guo J, Zhang T, Cao H, Li X, Liang H, Liu M, Zou Y, Zhang Y, Wang Y, Sun X, Hu F, Du Y, Mo X, Liu X, Yang Y, Yang H, Wu X, Zhang X, Jia H, Jiang H, Hou Y, Liu X, Su Y, Zhang M, Yang H, Wang J, Sun L, Liu L, Padyukov L, Lai L, Yamamoto K, Zhang X, Klareskog L, Xu X, Li Z.

Ann Rheum Dis. 2019 Jun;78(6):773-780. doi: 10.1136/annrheumdis-2018-214725. Epub 2019 Apr 1.

PMID:
30936065
13.

Translating genomic medicine to the clinic: challenges and opportunities.

Zhang H, Klareskog L, Matussek A, Pfister SM, Benson M.

Genome Med. 2019 Feb 22;11(1):9. doi: 10.1186/s13073-019-0622-1. Review.

14.

Complex Relationships of Smoking, HLA-DRB1 Genes, and Serologic Profiles in Patients With Early Rheumatoid Arthritis: Update From a Swedish Population-Based Case-Control Study.

Hedström AK, Rönnelid J, Klareskog L, Alfredsson L.

Arthritis Rheumatol. 2019 Sep;71(9):1504-1511. doi: 10.1002/art.40852. Epub 2019 Jul 24.

15.

Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis.

Lloyd KA, Wigerblad G, Sahlström P, Garimella MG, Chemin K, Steen J, Titcombe PJ, Marklein B, Zhou D, Stålesen R, Ossipova E, Lundqvist C, Ekwall O, Rönnelid J, Mueller DL, Karlsson MCI, Kaplan MJ, Skriner K, Klareskog L, Wermeling F, Malmström V, Grönwall C.

Front Immunol. 2019 Jan 4;9:3033. doi: 10.3389/fimmu.2018.03033. eCollection 2018.

16.

Retraction: Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition.

Amara K, Steen J, Murray F, Morbach H, Fernandez-Rodriguez BM, Joshua V, Engström M, Snir O, Israelsson L, Catrina AI, Wardemann H, Corti D, Meffre E, Klareskog L, Malmström V.

J Exp Med. 2019 Jan 7;216(1):245. doi: 10.1084/jem.2012148612112018r. Epub 2018 Dec 19. No abstract available.

17.

Reply.

Malmström V, Steen J, Klareskog L.

Arthritis Rheumatol. 2019 Feb;71(2):325-327. doi: 10.1002/art.40757. Epub 2019 Jan 9. No abstract available.

PMID:
30303296
18.

Generation and Characterization of Anti-Citrullinated Protein Antibody-Producing B Cell Clones From Rheumatoid Arthritis Patients.

Germar K, Fehres CM, Scherer HU, van Uden N, Pollastro S, Yeremenko N, Hansson M, Kerkman PF, van der Voort EIH, Reed E, Maassen H, Kwakkenbos MJ, Bakker AQ, Klareskog L, Malmström V, de Vries N, Toes REM, Lundberg K, Spits H, Baeten DL.

Arthritis Rheumatol. 2019 Mar;71(3):340-350. doi: 10.1002/art.40739. Epub 2019 Feb 2.

PMID:
30277007
19.

Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes.

Westra HJ, Martínez-Bonet M, Onengut-Gumuscu S, Lee A, Luo Y, Teslovich N, Worthington J, Martin J, Huizinga T, Klareskog L, Rantapaa-Dahlqvist S, Chen WM, Quinlan A, Todd JA, Eyre S, Nigrovic PA, Gregersen PK, Rich SS, Raychaudhuri S.

Nat Genet. 2018 Oct;50(10):1366-1374. doi: 10.1038/s41588-018-0216-7. Epub 2018 Sep 17.

20.

Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell-Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis.

Steen J, Forsström B, Sahlström P, Odowd V, Israelsson L, Krishnamurthy A, Badreh S, Mathsson Alm L, Compson J, Ramsköld D, Ndlovu W, Rapecki S, Hansson M, Titcombe PJ, Bang H, Mueller DL, Catrina AI, Grönwall C, Skriner K, Nilsson P, Lightwood D, Klareskog L, Malmström V.

Arthritis Rheumatol. 2019 Feb;71(2):196-209. doi: 10.1002/art.40699.

21.

Structural Basis of Cross-Reactivity of Anti-Citrullinated Protein Antibodies.

Ge C, Xu B, Liang B, Lönnblom E, Lundström SL, Zubarev RA, Ayoglu B, Nilsson P, Skogh T, Kastbom A, Malmström V, Klareskog L, Toes REM, Rispens T, Dobritzsch D, Holmdahl R.

Arthritis Rheumatol. 2019 Feb;71(2):210-221. doi: 10.1002/art.40698. Epub 2019 Jan 4.

PMID:
30152126
22.

Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis.

Engström M, Eriksson K, Lee L, Hermansson M, Johansson A, Nicholas AP, Gerasimcik N, Lundberg K, Klareskog L, Catrina AI, Yucel-Lindberg T.

J Transl Med. 2018 Jul 31;16(1):214. doi: 10.1186/s12967-018-1588-2.

23.

Systematic approach demonstrates enrichment of multiple interactions between non-HLA risk variants and HLA-DRB1 risk alleles in rheumatoid arthritis.

Diaz-Gallo LM, Ramsköld D, Shchetynsky K, Folkersen L, Chemin K, Brynedal B, Uebe S, Okada Y, Alfredsson L, Klareskog L, Padyukov L.

Ann Rheum Dis. 2018 Oct;77(10):1454-1462. doi: 10.1136/annrheumdis-2018-213412. Epub 2018 Jul 2.

24.

Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid Arthritis.

Titcombe PJ, Wigerblad G, Sippl N, Zhang N, Shmagel AK, Sahlström P, Zhang Y, Barsness LO, Ghodke-Puranik Y, Baharpoor A, Hansson M, Israelsson L, Skriner K, Niewold TB, Klareskog L, Svensson CI, Amara K, Malmström V, Mueller DL.

Arthritis Rheumatol. 2018 Dec;70(12):1933-1945. doi: 10.1002/art.40590. Epub 2018 Oct 18.

PMID:
29927106
25.

Memory T cells specific to citrullinated α-enolase are enriched in the rheumatic joint.

Pieper J, Dubnovitsky A, Gerstner C, James EA, Rieck M, Kozhukh G, Tandre K, Pellegrino S, Gebe JA, Rönnblom L, Sandalova T, Kwok WW, Klareskog L, Buckner JH, Achour A, Malmström V.

J Autoimmun. 2018 Aug;92:47-56. doi: 10.1016/j.jaut.2018.04.004. Epub 2018 May 28.

26.

Exposure to passive smoking and rheumatoid arthritis risk: results from the Swedish EIRA study.

Hedström AK, Klareskog L, Alfredsson L.

Ann Rheum Dis. 2018 Jul;77(7):970-972. doi: 10.1136/annrheumdis-2018-212973. Epub 2018 May 3.

27.

A Shared Epitope of Collagen Type XI and Type II Is Recognized by Pathogenic Antibodies in Mice and Humans with Arthritis.

Tong D, Lönnblom E, Yau ACY, Nandakumar KS, Liang B, Ge C, Viljanen J, Li L, Bãlan M, Klareskog L, Chagin AS, Gjertsson I, Kihlberg J, Zhao M, Holmdahl R.

Front Immunol. 2018 Apr 12;9:451. doi: 10.3389/fimmu.2018.00451. eCollection 2018.

28.

Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B-cell selection.

Lloyd KA, Steen J, Amara K, Titcombe PJ, Israelsson L, Lundström SL, Zhou D, Zubarev RA, Reed E, Piccoli L, Gabay C, Lanzavecchia A, Baeten D, Lundberg K, Mueller DL, Klareskog L, Malmström V, Grönwall C.

Eur J Immunol. 2018 Jun;48(6):1030-1045. doi: 10.1002/eji.201747446. Epub 2018 Apr 6.

29.

Smoking and susceptibility to rheumatoid arthritis in a Swedish population-based case-control study.

Hedström AK, Stawiarz L, Klareskog L, Alfredsson L.

Eur J Epidemiol. 2018 Apr;33(4):415-423. doi: 10.1007/s10654-018-0360-5. Epub 2018 Jan 31.

30.

Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.

Baecklund E, Backlin C, Rönnelid J, Toes R, Huizinga T, Åhlin E, Askling J, Hochberg FH, Klareskog L, Kay J, Smedby KE.

Scand J Rheumatol. 2018 Jul;47(4):270-275. doi: 10.1080/03009742.2017.1376108. Epub 2018 Jan 16.

PMID:
29336646
31.

Relationship between shift work and the onset of rheumatoid arthritis.

Hedström AK, Åkerstedt T, Klareskog L, Alfredsson L.

RMD Open. 2017 Aug 29;3(2):e000475. doi: 10.1136/rmdopen-2017-000475. eCollection 2017.

32.

Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants.

Rönnelid J, Hansson M, Mathsson-Alm L, Cornillet M, Reed E, Jakobsson PJ, Alfredsson L, Holmdahl R, Skriner K, Serre G, Lundberg K, Klareskog L.

Ann Rheum Dis. 2018 Feb;77(2):203-211. doi: 10.1136/annrheumdis-2017-211782. Epub 2017 Oct 25.

PMID:
29070529
33.

Seropositivity combined with smoking is associated with increased prevalence of periodontitis in patients with rheumatoid arthritis.

Eriksson K, Nise L, Alfredsson L, Catrina AI, Askling J, Lundberg K, Klareskog L, Yucel-Lindberg T.

Ann Rheum Dis. 2018 Aug;77(8):1236-1238. doi: 10.1136/annrheumdis-2017-212091. Epub 2017 Oct 6. No abstract available.

34.

Reply.

Ilar A, Alfredsson L, Wiebert P, Klareskog L, Bengtsson C.

Arthritis Care Res (Hoboken). 2018 Aug;70(8):1276. doi: 10.1002/acr.23436. No abstract available.

35.

Amount of smoking, duration of smoking cessation and their interaction with silica exposure in the risk of rheumatoid arthritis among males: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study.

Zeng P, Chen Z, Klareskog L, Alfredsson L, Bengtsson C, Jiang X.

Ann Rheum Dis. 2018 Aug;77(8):1238-1241. doi: 10.1136/annrheumdis-2017-212145. Epub 2017 Sep 15. No abstract available.

PMID:
28916713
36.

Working in cold environment and risk of developing rheumatoid arthritis: results from the Swedish EIRA case-control study.

Zeng P, Bengtsson C, Klareskog L, Alfredsson L.

RMD Open. 2017 Aug 16;3(2):e000488. doi: 10.1136/rmdopen-2017-000488. eCollection 2017.

37.

Oral contraceptives, breastfeeding and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.

Orellana C, Saevarsdottir S, Klareskog L, Karlson EW, Alfredsson L, Bengtsson C.

Ann Rheum Dis. 2017 Nov;76(11):1845-1852. doi: 10.1136/annrheumdis-2017-211620. Epub 2017 Aug 17.

38.

Occupation and Risk of Developing Rheumatoid Arthritis: Results From a Population-Based Case-Control Study.

Ilar A, Alfredsson L, Wiebert P, Klareskog L, Bengtsson C.

Arthritis Care Res (Hoboken). 2018 Apr;70(4):499-509. doi: 10.1002/acr.23321. Epub 2018 Mar 7.

39.

IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis.

Lundström SL, Hensvold AH, Rutishauser D, Klareskog L, Ytterberg AJ, Zubarev RA, Catrina AI.

Arthritis Res Ther. 2017 Aug 9;19(1):182. doi: 10.1186/s13075-017-1389-7.

40.

H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.

Brauner S, Folkersen L, Kvarnström M, Meisgen S, Petersen S, Franzén-Malmros M, Mofors J, Brokstad KA, Klareskog L, Jonsson R, Westerberg LS, Trollmo C, Malmström V, Ambrosi A, Kuchroo VK, Nordmark G, Wahren-Herlenius M.

Ann Rheum Dis. 2017 Oct;76(10):1755-1763. doi: 10.1136/annrheumdis-2016-210509. Epub 2017 Jul 31.

41.

Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis.

Grönwall C, Amara K, Hardt U, Krishnamurthy A, Steen J, Engström M, Sun M, Ytterberg AJ, Zubarev RA, Scheel-Toellner D, Greenberg JD, Klareskog L, Catrina AI, Malmström V, Silverman GJ.

J Autoimmun. 2017 Nov;84:29-45. doi: 10.1016/j.jaut.2017.06.004. Epub 2017 Jun 21.

PMID:
28647488
42.

VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis.

Guerreiro-Cacais AO, Norin U, Gyllenberg A, Berglund R, Beyeen AD; Rheumatoid Arthritis Consortium International (RACI), Petit-Teixeira E, Cornélis F, Saoudi A, Fournié GJ, Holmdahl R, Alfredsson L, Klareskog L, Jagodic M, Olsson T, Kockum I, Padyukov L.

Genes Immun. 2017 Mar;18(2):109. doi: 10.1038/gene.2017.7. No abstract available.

PMID:
28446790
43.

Dietary Intake of Polyunsaturated Fatty Acids and Pain in Spite of Inflammatory Control Among Methotrexate-Treated Early Rheumatoid Arthritis Patients.

Lourdudoss C, Di Giuseppe D, Wolk A, Westerlind H, Klareskog L, Alfredsson L, van Vollenhoven RF, Lampa J.

Arthritis Care Res (Hoboken). 2018 Feb;70(2):205-212. doi: 10.1002/acr.23245.

44.

DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis.

Meng W, Zhu Z, Jiang X, Too CL, Uebe S, Jagodic M, Kockum I, Murad S, Ferrucci L, Alfredsson L, Zou H, Klareskog L, Feinberg AP, Ekström TJ, Padyukov L, Liu Y.

Arthritis Res Ther. 2017 Mar 29;19(1):71. doi: 10.1186/s13075-017-1276-2.

45.

Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.

Manivel VA, Mullazehi M, Padyukov L, Westerlind H, Klareskog L, Alfredsson L, Saevarsdottir S, Rönnelid J.

Ann Rheum Dis. 2017 Sep;76(9):1529-1536. doi: 10.1136/annrheumdis-2016-210873. Epub 2017 Mar 23.

46.

Physical workload is associated with increased risk of rheumatoid arthritis: results from a Swedish population-based case-control study.

Zeng P, Klareskog L, Alfredsson L, Bengtsson C.

RMD Open. 2017 Mar 14;3(1):e000324. doi: 10.1136/rmdopen-2016-000324. eCollection 2017.

47.

Discovery of new candidate genes for rheumatoid arthritis through integration of genetic association data with expression pathway analysis.

Shchetynsky K, Diaz-Gallo LM, Folkersen L, Hensvold AH, Catrina AI, Berg L, Klareskog L, Padyukov L.

Arthritis Res Ther. 2017 Feb 2;19(1):19. doi: 10.1186/s13075-017-1220-5.

48.

VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis.

Guerreiro-Cacais AO, Norin U, Gyllenberg A, Berglund R, Beyeen AD; Rheumatoid Arthritis Consortium International (RACI), Petit-Teixeira E, Cornélis F, Saoudi A, Fournié GJ, Holmdahl R, Alfredsson L, Klareskog L, Jagodic M, Olsson T, Kockum I, Padyukov L.

Genes Immun. 2017 Jan;18(1):48-56. doi: 10.1038/gene.2016.49. Epub 2017 Jan 5. Erratum in: Genes Immun. 2017 Mar;18(2):109.

PMID:
28053322
49.

Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis.

Catrina AI, Svensson CI, Malmström V, Schett G, Klareskog L.

Nat Rev Rheumatol. 2017 Feb;13(2):79-86. doi: 10.1038/nrrheum.2016.200. Epub 2016 Dec 15. Review.

PMID:
27974851
50.

The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting.

Malmström V, Catrina AI, Klareskog L.

Nat Rev Immunol. 2017 Jan;17(1):60-75. doi: 10.1038/nri.2016.124. Epub 2016 Dec 5. Review.

PMID:
27916980

Supplemental Content

Loading ...
Support Center